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Age-associated declines in protein homeostasis mechanisms (“proteostasis”) are
thought to contribute to age-related neurodegenerative disorders. The increased
oxidative stress which occurs with aging can activate a key proteostatic process,
chaperone-mediated autophagy. This study investigated age-related alteration in
cerebrospinal fluid (CSF) concentrations of heat shock 70-kDa protein 8 (HSPA8),
a molecular chaperone involved in proteostatic mechanisms including chaperone-
mediated autophagy, and its associations with indicators of oxidative stress (8-hydroxy-
2′-deoxyguanosine [8-OHdG] and 8-isoprostane) and total anti-oxidant capacity.
We examined correlations between age, HSPA8, 8-OHdG, 8-isoprostane, and total
antioxidant capacity (TAC) in CSF samples from 34 healthy subjects ranging from 20 to
75 years of age. Age was negatively associated with HSPA8 (ρ = −0.47; p = 0.005). An
age-related increase in oxidative stress was indicated by a positive association between
age and 8-OHdG (ρ = 0.61; p = 0.0001). HSPA8 was moderately negatively associated
with 8-OHdG (ρ = −0.58; p = 0.0004). Age and HSPA8 were weakly associated with 8-
isoprostane and TAC (range of ρ values: −0.15 to 0.16). Our findings in this exploratory
study suggest that during healthy aging, CSF HSPA8 may decrease, perhaps due in
part to an increase in oxidative stress. Our results also suggest that 8-OHdG may be
more sensitive than 8-isoprostane for measuring oxidative stress in CSF. Further studies
are indicated to determine if our findings can be replicated with a larger cohort, and if
the age-related decrease in HSPA8 in CSF is reflected by a similar change in the brain.
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INTRODUCTION
Aging is the most consistent known risk factor for developing progressive neurodegenerative
disease (Jeppesen et al., 2011). An important contributor to this risk is likely to be the increased
oxidative stress that develops in the aging brain (Floyd and Hensley, 2002). Age-associated
declines in protein homeostasis (“proteostasis”) mechanisms may also be involved. Oxidative
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mechanisms are likely to play a role in the formation of misfolded
protein aggregates that are pathological hallmarks of age-
associated neurodegenerative disorders, because they promote
protein aggregation (Squier, 2001). Accumulation of misfolded
and unfolded proteins in the endoplasmic reticulum (ER) causes
“ER stress” which activates the unfolded protein response (UPR).
If this response fails to reduce the protein load in the ER then
cell death may result (Cuanalo-Contreras et al., 2013). A second
proteostatic mechanism in addition to the UPR is autophagy,
which removes damaged proteins and organelles by degrading
them within lysosomes (Cuanalo-Contreras et al., 2013). Three
types of autophagic processes are recognized (reviewed by
Filomeni et al., 2015), namely macroautophagy (sequestration
of damaged organelles into autophagosomes), microautophagy
(engulfment of cytosolic material by lysosomes), and chaperone
mediated autophagy (CMA), through which selected cytosolic
proteins translocate to the lysosome for degradation without the
requirement for vesicle formation (Cuervo, 2010). Autophagy
can be organelle-specific, including mitophagy, reticulophagy,
and ribophagy (Osellame and Duchen, 2014). Oxidative stress
can activate autophagic processes including CMA (Kiffin et al.,
2004).
Heat shock 70-kDa protein 8 (HSPA8, also known as Hsc70
and Hsc73) is a cytosolic molecular chaperone involved in
multiple proteostasis mechanisms including CMA (Liao and
Tang, 2014). We recently measured HSPA8 in cerebrospinal fluid
(CSF) samples from patients with sporadic Parkinson’s disease
(PD), PD patients carrying leucine-rich repeat kinase 2 (LRRK2)
gene mutations, healthy control subjects carrying LRRK2
mutations, and healthy controls without LRRK2 mutations
(Loeﬄer et al., 2016). LRRK2 gene mutations are the most
common cause of inherited PD (Vilas et al., 2016). We included,
in that study, data from 23 healthy control subjects without
LRRK2 mutations ranging from 45 to 75 years old. At the
same time, we measured HSPA8 in 11 younger control subjects
ranging from 20 to 43 years of age who were not included in
the study. Our unpublished results from these control subjects
suggested associations between age and HSPA8 concentrations.
The age-related changes in HSPA8 in the human CNS are
unknown, and the literature contains conflicting reports with
regard to its alterations with age in experimental animals (Unno
et al., 2000; Calabrese et al., 2004; Gleixner et al., 2014). In
this study, we present our findings with regard to age-related
changes in CSF HSPA8, and the associations between this protein
and oxidative stress biomarkers 8-hydroxy-2′-deoxyguanosine
(8-OHdG) (Valavanidis et al., 2009) and 8-isoprostane (8-ISO)
(Morrow et al., 1992) as well as total antioxidant capacity (TAC)
(Bartosz, 2003).
MATERIALS AND METHODS
Study Subjects
Lumbar CSF samples were obtained from 34 healthy subjects by
Jan Aasly, M.D., Ph.D. (St. Olav’s Hospital, Trondheim, Norway),
using the Parkinson’s Progression Markers Initiative (PPMI)
biospecimen collection procedures (Parkinson’s Progression
Markers Initiative, 2014). CSF was collected from fasting subjects
between 8 and 9 AM; within 15 min of collection, it was
centrifuged at 2000 × g for 10 min at room temperature, then
frozen within 60 min of collection and stored at −80◦C. The
study was approved by the Regional Committee for Medical
Research Ethics, Central Norway, for the procedures performed
at St. Olav’s Hospital (subject recruiting and obtaining of CSF
samples). Written informed consent was obtained from all
subjects, in accordance with the Declaration of Helsinki, before
lumbar punctures. The subjects were tested for and lacked known
PD-related mutations in the LRRK2, PARK2, PARK7, PINK1,
and SNCA genes, and had no detectable cognitive or other
neurological impairments. The study was given exempt status by
the Institutional Review Board of Beaumont Health (Beaumont
Hospital-Royal Oak, Royal Oak, MI, USA) where measurements
of HSPA8, 8-OHdG, 8-ISO, and TAC were performed.
Measurements of HSPA8, 8-OHdG,
8-ISO, and TAC in CSF Samples
HSPA8 was measured with MyBioSource’s Heat Shock 70kDa
Protein 8 (HSPA8) ELISA Kit (cat. # MBS2023476). The detection
limit for this assay was stated by the manufacturer to be
0.128 ng/mL. 8-OHdG, 8-ISO, and TAC were measured with
kits from Cayman Chemicals (Ann Arbor, MI): DNA/RNA
Oxidative Damage ELISA Kit (cat. # 589320; detection limit
30 pg/mL), 8-Isoprostane ELISA Kit (cat. # 516351; detection
limit 2.7 pg/mL), and Antioxidant Assay Kit [cat. # 709001;
detection limit 44 µM (0.044 mM) Trolox equivalents]. (The
DNA/RNA Oxidative Damage kit measures all three oxidized
guanine species, namely 8-OHdG, 8-hydroxyguanosine, and 8-
hydroxyguanine; this cumulative measurement is referred to in
this study as 8-OHdG. The Antioxidant Assay Kit measures the
cumulative effects of endogenous and food-derived antioxidants.)
HSPA8 was measured in single wells using undiluted CSF.
8-hydroxy-2′-deoxyguanosine and 8-ISO were measured in
duplicate after diluting samples 1:4 and 1:2, respectively, with EIA
buffer. TAC was measured in duplicate in undiluted samples. The
concentrations of 8-OHdG, 8-ISO, and TAC used in statistical
analyses were mean values of duplicate measurements. Two
ELISA plates were used for HSPA8 measurements, four plates
were used for 8-OHdG measurements, three plates were used
for 8-ISO measurements, and three plates were used for TAC
measurements. The coefficients of variation (CV), calculated only
for the 8-OHdG, 8-ISO, and TAC assays, were 3.6, 2.0, and 10.4.
Statistical Analyses
HSPA8, 8-OHdG, 8-ISO, and TAC concentrations were
summarized with medians, interquartile ranges, and ranges. The
associations between these measures, and between each measure
and subject age, were examined with Spearman’s rank-order
correlation coefficient (Spearman’s rho). Gender differences for
each measure were explored with non-parametric summaries,
Wilcoxon’s rank sum test, and scatter plots which included
LOWESS (“locally weighted scatterplot smoother”) lines.
Because the males in this study tended to be younger than the
females, the non-graphical comparisons of data between genders
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used data only from subjects at least 40 years old (9 men and 16
women, with median ages of 60 and 64, respectively). Statistical
significance was set at p < 0.05 for all analyses; p-values were
not adjusted for multiple testing. The SAS System for Windows
version 9.3 (SAS Institute Inc., Cary, NC, USA) and Minitab
release 14 (Minitab Inc., State College, PA, USA) were used for
statistical analysis.
RESULTS
Patient Demographics
Our study subjects consisted of 18 males and 16 females. Their
mean age (±SD) was 51.3 ± 17.9 years, with a range from 20 to
75 years.
HSPA8, 8-OHdG, 8-ISO, and TAC
Concentrations in CSF
Summary statistics (medians, 25th and 75th percentiles,
and ranges) for CSF HSPA8, 8-OHdG, 8-ISO, and TAC
concentrations are shown in Table 1. All four of these
measures were detected in all samples, although some of
the HSPA8 and 8-ISO measurements were only slightly
greater than the lower limits of sensitivity for their respective
assays (lowest value for HSPA8 = 0.14 ng/mL, lower limit of
sensitivity = 0.128 ng/mL; lowest value for 8-ISO = 3.2 pg/mL,
lower limit of sensitivity = 2.7 pg/mL). Comparison of the
two oxidative stress biomarkers indicated that 8-OHdG
concentrations (median = 784.9 pg/mL) were far higher than
those for 8-ISO (median= 6.5 pg/mL).
Associations between Subject Age,
HSPA8, Oxidative Stress Biomarkers,
and Total Antioxidant Capacity in CSF
The associations involving subject age and the other measures
are shown in Table 2. Age was negatively associated with HSPA8
(ρ = −0.47; p = 0.005) and positively associated with 8-OHdG
(ρ = 0.61; p = 0.0001). Age was weakly associated with 8-ISO
(ρ = 0.16) and TAC (ρ = 0.10). HSPA8 was negatively correlated
with 8-OHdG (ρ=−0.58; p= 0.0004), but poorly correlated with
8-ISO (ρ = −0.15) and TAC (ρ = 0.004). 8-OHdG, 8-ISO, and
TAC were poorly correlated with each other (ρ values: 8-OHdG
vs. 8-ISO: 0.12; 8-OHdG vs. TAC: 0.17; 8-ISO vs. TAC:−0.29).
TABLE 1 | Summary statistics for HSPA8, 8-OHdG, 8-ISO, and total
antioxidant capacity (TAC) concentrations in CSF from 34 healthy
subjects.
Measure Units Median 25th
percentile
75th
percentile
Range
HSPA8 ng/mL 0.45 0.36 0.64 0.14–0.95
8-OHdG pg/mL 784.9 712.5 922.7 416.9–1159.1
8-ISO pg/mL 6.5 5.3 8.7 3.2–16.7
TAC mM 0.38 0.33 0.40 0.24–0.59
HSPA8, heat shock 70-kDa protein 8; 8-ISO, 8-isoprostane; 8-OHdG, 8-hydroxy-
2′-deoxyguanosine; TAC, total antioxidant capacity.
TABLE 2 | Associations between age, HSPA8, 8-OHdG, 8-ISO, and TAC in
CSF from 34 healthy subjects.
HSPA8 8-ISO 8-OHdG TAC
Age −0.469 0.165 0.614 0.100
0.005 0.35 0.0001 0.57
HSPA8 −0.148 −0.576 0.004
0.40 0.0004 0.98
8-ISO 0.117 −0.287
0.51 0.10
8-OHdG 0.173
0.33
Top number, Spearman’s rho; bottom number, p-value; HSPA8, heat shock 70-
kDa protein 8; 8-ISO, 8-isoprostane; 8-OHdG, 8-hydroxy-2′-deoxyguanosine; TAC,
total antioxidant capacity.
Gender-Related Differences in HSPA8,
8-OHdG, 8-ISO, and TAC
When statistical analyses were limited to subjects ≥ 40 years of
age to allow comparison of similar-aged gender cohorts, HSPA8
concentrations were similar between genders (median values
for men and women, respectively: 0.44 and 0.40 ng/mL). The
concentrations of 8-OHdG and 8-ISO were also similar between
genders (median values: 8-OHdG: men, 842 pg/mL, women,
857 pg/mL; 8-ISO: men, 6.00 pg/mL, women, 6.95 pg/mL).
However, measurements of TAC suggested that its levels might
be higher in men than in women (median values: men, 0.402 mM,
women, 0.366 mM; p= 0.018).
Examination of the slopes of LOWESS lines revealed that
HSPA8 concentrations appeared to decline similarly with age,
after age 45, in both genders (Figure 1). 8-OHdG levels tended
to increase with age with similar patterns for both genders
(Figure 2). The LOWESS lines in the scatterplot of age versus 8-
ISO (not shown) suggested a tendency for 8-ISO to increase with
age in men beginning at about age 40, but there did not appear to
FIGURE 1 | Distribution of CSF HSPA8 concentrations as a function of
age in healthy adults. HSPA8 concentration was negatively correlated with
subject age (Spearman’s ρ = −0.47; p = 0.005). LOWESS curves (dashed
lines, men; solid lines, women) suggested that HSPA8 may decrease similarly
in men and women after age 45. An age-related decrease in HSPA8 was not
seen in men prior to age 45. (HSPA8, heat shock 70-kDa protein 8).
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FIGURE 2 | Distribution of CSF concentrations of 8-OHdG as a
function of age in healthy adults. Age and 8-OHdG were strongly positively
associated (ρ = 0.61; p = 0.0001). 8-OHdG levels tended to increase with
age with similar patterns for both genders. (dashed lines, men; solid lines,
women; 8-OHdG, 8-hydroxy-2′-deoxyguanosine).
be a relationship between age and 8-ISO levels for women. TAC
levels in women (scatter plots not shown) appeared to remain
constant during aging, while there was not enough information to
draw conclusions regarding possible age-related changes in TAC
in men.
DISCUSSION
Our main finding in this study was that the CSF concentration
of HSPA8 decreased with age (ρ = −0.47; p = 0.005). An
age-related increase in oxidative stress was suggested by the
association between age and 8-OHdG (ρ = 0.61; p = 0.0001)
although no associations with age were found for the other
oxidative stress marker 8-ISO or for TAC. HSPA8 was moderately
associated with 8-OHdG (ρ = −0.58; p = 0.0004). These
findings suggest that the age-related increase in oxidative stress
in the CNS might contribute to an age-associated decrease in
HSPA8.
We found relatively weak correlations between CSF
concentrations of 8-OHdG, 8-ISO, and TAC. Our assays
for 8-OHdG and 8-ISO evaluated different oxidative parameters;
the DNA/RNA Oxidative Damage kit measures nucleic acid
oxidation (8-OHdG, 8-OHG, and 8-hydroxyguanine) while
our 8-ISO ELISA measures lipid peroxidation. Both 8-OHdG
and 8-ISO are widely used as markers for oxidative stress (see
reviews by Montuschi et al., 2007 and Gmitterová et al., 2009)
and there is no consensus as to which is more sensitive. TAC
has also been measured previously in CSF (Lönnrot et al., 1996;
Mandrioli et al., 2006). Although TAC is not a measure of
oxidative stress, its decrease indicates a reduction in antioxidant
protection, which could result in increased oxidative stress.
Among these three markers, we found only 8-OHdG to be
moderately associated, in all study subjects, with subject age
(ρ = 0.61). [Although 8-ISO was strongly positively correlated
with age in men ≥40 (ρ = 0.84) and 8-OHdG and 8-ISO
were moderately associated in this subset (ρ = 0.53), these
results were based on data from only nine men.] Our results
suggest that 8-OHdG may be more sensitive than 8-ISO or
TAC for detecting oxidative stress in CSF. Previous studies
suggested that measurements of 8-OHdG and 8-ISO can be
used to detect age-related increases in oxidative stress in CSF.
Guest et al. (2014) reported an increase of 15% in 8-OHdG
and 5.7% in F2-isoprostane in CSF between normal subjects
≤ 45 years old and those > 45 years old, and Peskind et al.
(2014) found a 10% increase in F2-isoprostanes from age 45 to
age 71. Montine et al. (2002, 2011) also found an age-related
increase in F2-isoprostanes in one study but not in a different
study.
The mitochondrial respiratory chain is the main source of
reactive oxygen species (ROS) for autophagy signaling (Osellame
and Duchen, 2014), so our finding of a negative association
(ρ = −0.58; p = 0.0004) between the oxidative stress marker
8-OHdG and HSPA8 may be relevant to the selective removal
of mitochondria by autophagy, which is termed mitophagy.
This process is initiated by damaged mitochondria (Osellame
and Duchen, 2014). Chronic impairment of mitochondrial
function results in extensive mitochondrial production of ROS,
which shift from non-selective autophagy inducers to the more
selective process of mitophagy in an effort to save the cell by
removing injured mitochondria (Filomeni et al., 2015). ROS can
cause irreversible oxidative modification and loss of function
to mitochondrial proteins, lipids, and DNA. Paradoxically,
while mild oxidative stress may trigger mitophagy (Frank
et al., 2012), increased oxidative stress, paired with apoptotic
proteases, can also inactivate mitophagy, allowing cell death
mechanisms to proceed (Kubli and Gustafsson, 2012). Whether
the negative association we found in CSF between oxidative
stress (as indicated by 8-OHdG) and HSPA8 might indicate a
similar correlation between oxidative stress and mitophagy is
unknown.
Oxidative stress is increased in postmortem brain specimens
from healthy elderly individuals (Smith et al., 1991; Mecocci
et al., 1993; Agarwal and Sohal, 1994; Dei et al., 2002). The
influence of normal aging, and its associated increase in oxidative
stress, on autophagy in the human CNS is unknown. Our
findings suggest that CSF concentrations of the autophagy-
associated molecular chaperone HSPA8 may decrease with age.
If these results can be confirmed in a larger cohort, then
the relationship of CSF HSPA8 to its brain levels should be
examined. If the age-related alteration in CSF HSPA8 reflects
a similar change in the brain, then this protein may offer
a biomarker for monitoring brain autophagy during normal
aging. While HSPA8 alone would likely not be sufficient for this
purpose, its measurement could be paired with other autophagy-
related proteins such as Beclin 1 and LC3B (Li et al., 2015).
Longitudinal monitoring of CSF markers for autophagy might
be worthwhile for individuals with known genetic risk factors
for neurodegenerative disorders, such as homozygosity for the
gene encoding for Apolipoprotein E4, which increases the risk
of developing Alzheimer’s disease by 10-fold (Eisenstein, 2011;
Rohn et al., 2014) and PD-associated mutations in the LRRK2
gene.
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The interpretation of our results should include the following:
(a) HSPA8 is a multifunctional protein (Liao and Tang, 2014);
although a critical protein for CMA, it is not rate-limiting
for this process, so its cytosolic concentrations may not
correlate with CMA activity (Cuervo and Dice, 2000). It
should therefore not be considered as a direct indicator of
CMA activity.
(b) Whether our ELISAs detected biologically active HSPA8,
or inactive forms of this protein (or its degradation
products), is also unknown. Although alterations in the
CSF concentrations of HSPA8 might reflect changes in its
production in the brain, HSPA8 could also be present in
CSF due to release by dying or dead cells.
(c) A limitation of this study is that because our analysis of
gender differences for HSPA8 and oxidative measures was
performed on data from only 9 men and 16 women in order
to compare similar-aged gender cohorts, our findings with
regard to possible gender differences for these parameters
are preliminary.
We conclude that HSPA8 may decrease in CSF during
normal aging, and increased oxidative stress may contribute
to this alteration. Further studies, including investigation of
the relationship between CSF and brain levels of HSPA8, are
indicated to determine the significance of these findings.
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